Clinical trial · Observational
PTeye in Parathyroid Adenoma
Do PTeye Score Correlate With Biochemical Markers in Parathyroid Adenoma?
NCT06913296CI-TRIAL-00088197recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Identifying the parathyroids is compulsory for success of parathyroidectomy for parathyroid adenoma. Near-infrared autofluorescence devices have been proposed as useful intraoperative tools for the identification of parathyroid glands. The aim of the present study is to evaluate the correlation of PTeye autofluorescence device with biochemical data of parathyroid adenoma patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Parathyroid Adenoma | Parathyroid Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| parathyroidectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Parathyroid adenoma patients
- description
- Patients undergoing surgery for parathyroid adenoma will be enrolled in this study. Parathyroid glands will be identified with the application of autofluorescence device PTeye and the values obtained by the device after parathyroid gland recognition will be registered.
- interventionNames
- Procedure: parathyroidectomy
Primary outcomes (1)
- measure
- assess the correlation of PTeye values with biochemical data
- timeFrame
- intraoperatively and 1st postoperative day
- description
- Biochemical data included are pre- and postoperative parathyroid hormone, serum calcium, phosphorus and vitamin D levels
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \>18 years old * primary hyperparathyroidism caused by adenoma * patient's informed consent acquired Exclusion Criteria: * Secondary and tertiary hyperparathyroidism * Re-operation for adenoma * Previous neck surgery * Patient enrolled in another study that may affect the results of this study
References
Publications (0)
Data not yet available
No reference posted for this study.